Drug profile · INN
angiotensin ii acetate
ANGIOTENSIN LL ACETATE
angiotensin ii acetate (ANGIOTENSIN LL ACETATE) is a type-1 angiotensin ii receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — angiotensin ii acetate
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
angiotensin ii acetate (ANGIOTENSIN LL ACETATE) is a type-1 angiotensin ii receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Type-1 angiotensin II receptor agonist
Primary target: Type-1 angiotensin II receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is angiotensin ii acetate?
angiotensin ii acetate (ANGIOTENSIN LL ACETATE) is a type-1 angiotensin ii receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for angiotensin ii acetate?
ANGIOTENSIN LL ACETATE is a marketed brand name for angiotensin ii acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of angiotensin ii acetate?
angiotensin ii acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.